Company Description
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.
The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Country | United States |
Founded | 1932 |
IPO Date | Nov 3, 1995 |
Industry | Medical Distribution |
Sector | Healthcare |
Employees | 25,000 |
CEO | Stanley M. Bergman |
Contact Details
Address: 135 Duryea Rd Melville, New York 11747 United States | |
Phone | (631) 843-5500 |
Website | henryschein.com |
Stock Details
Ticker Symbol | HSIC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001000228 |
CUSIP Number | 806407102 |
ISIN Number | US8064071025 |
Employer ID | 11-3136595 |
SIC Code | 5047 |
Key Executives
Name | Position |
---|---|
Stanley M. Bergman | Executive Chairman and Chief Executive Officer |
James P. Breslawski | Executive Vice Chairman and President |
Ronald N. South | Senior Vice President and Chief Financial Officer |
Steven Paladino | Executive Director |
Mark E. Mlotek | Executive Vice President, Chief Strategic Officer and Executive Director |
Bradford C. Connett | Chief Executive Officer of North America Distribution Group |
Michael Saul Ettinger | Executive Vice President and Chief Operating Officer |
Olga Timoshkina | Vice President of Corporate Finance, Chief Accounting Officer and Corporate Controller |
Christopher Pendergast | Senior Vice President and Chief Technology Officer |
Graham Stanley | Vice President of Investor Relations and Strategic Finance Project Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 29, 2024 | SD | Form - SD |
May 24, 2024 | 8-K | Current Report |
May 7, 2024 | 10-Q | Quarterly Report |
May 7, 2024 | 8-K | Current Report |
Apr 10, 2024 | ARS | Filing |
Apr 10, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 10, 2024 | DEF 14A | Other definitive proxy statements |
Mar 20, 2024 | 144 | Filing |
Mar 18, 2024 | 144 | Filing |
Mar 5, 2024 | 144 | Filing |